Safety and effectiveness of percutaneous coronary intervention using rotational atherectomy and new-generation drug-eluting stents for calcified coronary artery lesions in patients with chronic kidney disease.


Journal

Indian heart journal
ISSN: 2213-3763
Titre abrégé: Indian Heart J
Pays: India
ID NLM: 0374675

Informations de publication

Date de publication:
Historique:
received: 02 08 2020
revised: 19 01 2021
accepted: 24 04 2021
entrez: 22 6 2021
pubmed: 23 6 2021
medline: 21 10 2021
Statut: ppublish

Résumé

Coronary artery calcification is an important factor influencing revascularisation outcomes in patients with chronic kidney disease (CKD). Lesion preparation using rotational atherectomy (RA) may help adequately modify calcified plaques and facilitate the achievement of optimal clinical outcomes in these patients. In this study, we assessed the safety and effectiveness of percutaneous coronary intervention (PCI) using RA followed by new-generation drug-eluting stent (DES) implantation in patients with CKD and calcified coronary artery disease (CAD). From November 2014 to October 2019, a total of 203 patients with calcified CAD who underwent RA followed by second- or third-generation DES implantation at our centre were included in the study. Mild, moderate, and severe CKD was present in 38%, 55.5%, and 6.5% of the patients, respectively. Diffused coronary calcifications were present in 85%. Procedural success was 97.5% with minimal periprocedural complications. In-stent restenosis occurred in one patient (0.5%); major adverse cardiovascular and cerebrovascular events were reported in 22 patients (10.8%); cardiac death occurred in eight patients during follow-up. Percutaneous coronary intervention using RA followed by second- or third-generation DES implantation is feasible and safe with high procedural success and low in-stent restenosis in CKD patients with calcified coronary lesions.

Identifiants

pubmed: 34154753
pii: S0019-4832(21)00099-7
doi: 10.1016/j.ihj.2021.04.007
pmc: PMC8322809
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

342-346

Informations de copyright

Copyright © 2021 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors have no conflicts of interest to declaration.

Références

PLoS One. 2016 May 19;11(5):e0153478
pubmed: 27195786
Ann Intern Med. 2002 Oct 1;137(7):563-70
pubmed: 12353943
J Am Coll Cardiol. 2019 Oct 8;74(14):1823-1838
pubmed: 31582143
J Am Heart Assoc. 2016 Nov 7;5(11):
pubmed: 27821401
J Invasive Cardiol. 2018 Jan;30(1):10-17
pubmed: 28915510
Lancet. 2013 Jul 27;382(9889):339-52
pubmed: 23727170
J Am Coll Cardiol. 2003 Jan 1;41(1):47-55
pubmed: 12570944
Curr Cardiol Rev. 2013 Nov;9(4):331-9
pubmed: 24527682
Circ J. 2009 Nov;73(11):2042-9
pubmed: 19749479
Circulation. 2011 Dec 6;124(23):e574-651
pubmed: 22064601
Clin J Am Soc Nephrol. 2009 Dec;4(12):1892-900
pubmed: 19833908
J Cardiol. 2010 Mar;55(2):232-7
pubmed: 20206077
EuroIntervention. 2018 May 20;14(1):102-111
pubmed: 29155387
JAMA Cardiol. 2017 Jun 1;2(6):635-643
pubmed: 28329057
BMC Nephrol. 2017 Jan 14;18(1):23
pubmed: 28088175
JACC Cardiovasc Interv. 2016 Oct 24;9(20):2097-2109
pubmed: 27692820
Korean Circ J. 2017 Mar;47(2):222-230
pubmed: 28382078
J Am Coll Cardiol. 2019 Feb 5;73(4):400-411
pubmed: 30704571
Int J Cardiol. 2013 Oct 9;168(4):3741-6
pubmed: 23845772
BMC Nephrol. 2013 Jul 17;14:152
pubmed: 23865418
Curr Cardiol Rep. 2013 Mar;15(3):340
pubmed: 23338722
Eur J Intern Med. 2017 Sep;43:28-35
pubmed: 28400078
Eur Heart J. 2016 Oct 21;37(40):3090-3095
pubmed: 26957421
Lancet. 2010 Jun 12;375(9731):2073-81
pubmed: 20483451
Circ J. 2003 Jul;67(7):617-21
pubmed: 12845186
PLoS One. 2018 Mar 21;13(3):e0192895
pubmed: 29561894
Catheter Cardiovasc Interv. 2017 Apr;89(5):841-848
pubmed: 27567020
Lancet Diabetes Endocrinol. 2015 Jul;3(7):514-25
pubmed: 26028594
Int J Cardiol. 2019 Jun 15;285:14-20
pubmed: 30904279
J Am Coll Cardiol. 2014 Dec 23;64(24):e139-e228
pubmed: 25260718
Eur Heart J. 2014 Oct 1;35(37):2541-619
pubmed: 25173339
Int Urol Nephrol. 2019 Jul;51(7):1219-1227
pubmed: 31020627
Circ Res. 2016 Feb 19;118(4):620-36
pubmed: 26892962
J Interv Cardiol. 2017 Apr;30(2):124-133
pubmed: 27990696
J Am Coll Cardiol. 2015 Sep 15;66(11):1209-1220
pubmed: 26361150
Can J Kidney Health Dis. 2015 Aug 12;2:29
pubmed: 26269747

Auteurs

Fazila-Tun-Nesa Malik (FT)

Department of Cardiology, National Heart Foundation Hospital & Research Institute, Bangladesh. Electronic address: fazilamalik@yahoo.com.

Md Kalimuddin (M)

Department of Cardiology, National Heart Foundation Hospital & Research Institute, Bangladesh.

Nazir Ahmed (N)

Department of Cardiology, National Heart Foundation Hospital & Research Institute, Bangladesh.

Mohammad Badiuzzaman (M)

Department of Cardiology, National Heart Foundation Hospital & Research Institute, Bangladesh.

Abdul Kayum Khan (AK)

Department of Cardiology, National Heart Foundation Hospital & Research Institute, Bangladesh.

Ashok Dutta (A)

Department of Cardiology, National Heart Foundation Hospital & Research Institute, Bangladesh.

Tawfiq Shahriar Huq (TS)

Department of Cardiology, National Heart Foundation Hospital & Research Institute, Bangladesh.

Dhiman Banik (D)

Department of Cardiology, National Heart Foundation Hospital & Research Institute, Bangladesh.

Mir Nesaruddin Ahmed (MN)

Department of Cardiology, National Heart Foundation Hospital & Research Institute, Bangladesh.

Md Habibur Rahman (MH)

Department of Cardiology, National Heart Foundation Hospital & Research Institute, Bangladesh.

Md Abu Tareq Iqbal (MAT)

Department of Cardiology, National Heart Foundation Hospital & Research Institute, Bangladesh.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH